Adult Growth Hormone Deficiency

  • Mar 26, 2018 globenewswire.com
    Strongbridge Biopharma plc to Host Investor and Analyst Day on April 5, 2018 – GlobeNewswire
    Read More
  • Mar 05, 2018 globenewswire.com
    Aeterna Zentaris Provides Update on Previously Disclosed Class Action Lawsuit – GlobeNewswire
    Read More
  • FDA approves Ferring’s ZOMACTON to treat Growth Hormone Deficiency in Adults – BSI bureau
    Read More
  • Feb 01, 2018 www.empr.com
    Zomacton Approved to Treat Growth Hormone Deficiency in Adults – Monthly Prescribing Reference
    Read More
  • Jan 31, 2018 www.prnewswire.com
    Ferring’s ZOMACTON® (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults – PR Newswire
    Read More
  • Jan 24, 2018 seekingalpha.com
    Strongbridge Biopharma: Are There Further Upsides To This Stellar Grower? – Seeking Alpha
    Read More
  • Investors continue to like Aeterna’s Macrilen deal – The Pharma Letter
    Read More
  • Jan 17, 2018 globenewswire.com
    Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris – GlobeNewswire
    Read More
  • Dec 21, 2017 www.healio.com
    FDA approves oral ghrelin agonist for adult GH deficiency diagnosis – Healio
    Read More

Connect. Empower. Inspire.